Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Adult pre-emptive kidney transplantation: a paired kidney analysis

T Debska-Slizien, B Bzoma, G Moszkowska, I Skora, A Chamienia, D Zadrozny, Z Sledzinski, B Rutkowski

Ann Transplant 2009; 14(1): 24-25 :: ID: 880287

Abstract

Background: The present study compares the outcome of 43 adults transplanted without prior dialysis i.e. pre-emptive transplantation (PET) and their kidney pairs transplanted after variable duration of dialysis i.e.pre-transplantation dialysis (PTD). We investigated the potential advantages of PET.
Material/Methods: In the period from November'2003 to December'2008, 43 patients (30M, 13F) received PET (4 living/39 cadaver donors). 36/43 PET patients (24M, 22F) - mean age 40.4±13.9 years had their PTD kidney pair (26M, 10F) - mean age 44.6±13 years. PTD patients remained on dialysis for 3.5 to 180 (mean 38) months before transplantation.
Results: Mean waiting time for transplantation was 3.3 vs. 23 months (p<0.05)  and the mean Charlson co-morbidity index was 2.4 vs. 2.8 in PET and PTD group (NS). Studied groups (PET vs. PTD) did not differ significantly with respect to: number of mismatches, one year patient (97.2% vs. 97.2%) and graft survival (88.9% vs. 88.9%), one-year death censored graft survival (91.7% vs. 91.7%) and the incidences of acute rejection (28% vs. 33%). 4 (11%) PET and 10 (28%) PTD patients experienced delayed graft function (p<0.05). Estimated GFR (MDRD and C-G) during one year after transplantation was similar in both groups but the comparison of the creatinine concentration revealed that it was significantly lower in PET group and stable during observation. (p<0.05). More PTD patients had professional activity before and after transplantation (p<0.05).
Conclusions: Our single-centre results confirm that PET is an optimal mode of
renal replacement therapy for both medical and socioeconomic reasons.

Keywords: Kidney Transplantation

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358